MedTrace Logo

High-cutoff Hemodialyzer to Reduce Chronic Inflammation in Hemodialysis Patients

NCT00974779 · Status: COMPLETED · Phase: PHASE2/PHASE3 · Type: INTERVENTIONAL · Enrollment: 19

Last updated 2012-01-18

No results posted yet for this study

Summary

The purpose of this study is to test whether a dialyzer with a higher than usual permeability for proteins can eliminate proinflammatory proteins from the blood of patients on regular maintenance hemodialysis who have chronically elevated levels of inflammation markers such as C-reactive protein (CRP) in their blood.

Conditions

Interventions

DEVICE

HCO1100 dialyzer

Thrice weekly dialysis using the HCO1100 dialyzer for 4.5h, 2 weeks

DEVICE

regular dialysis polyamide

Continuation of the regular hemodialysis using polyamide high-flux hemodialysers

Sponsors & Collaborators

  • Gambro Dialysatoren GmbH

    collaborator INDUSTRY

  • KfH Kuratorium für Dialyse und Nierentransplantation e.V., Neu Isenburg, Germany

    collaborator UNKNOWN

  • Martin-Luther-Universität Halle-Wittenberg

    lead OTHER

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
QUADRUPLE
Model
CROSSOVER

Eligibility

Min Age
18 Years
Max Age
80 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2009-11-30
Primary Completion
2011-08-31
Completion
2011-12-31

Countries

  • Germany

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00974779 on ClinicalTrials.gov